Aperio Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $110K | Sell |
16,834
-3,001
| -15% | -$19.6K | ﹤0.01% | 2374 |
|
|
2020
Q3 | $132K | Buy |
19,835
+629
| +3% | +$4.19K | ﹤0.01% | 2292 |
|
|
2020
Q2 | $160K | Buy |
19,206
+8,439
| +78% | +$70.3K | ﹤0.01% | 2217 |
|
|
2020
Q1 | $83K | Buy |
+10,767
| New | +$83K | ﹤0.01% | 2233 |
|
|
2019
Q4 | – | Sell |
-10,678
| Closed | -$79K | – | 2329 |
|
|
2019
Q3 | $79K | Buy |
10,678
+4,406
| +70% | +$32.6K | ﹤0.01% | 2256 |
|
|
2019
Q2 | $70K | Buy |
+6,272
| New | +$70K | ﹤0.01% | 2476 |
|